Collegium Pharmaceutical Inc. (COLL)
NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 21.93 0.00%
COLL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $713.94M
- P/E (TTM)
- 17.27
- Forward P/E
- 3.30
- EPS (TTM)
- $1.27
- Dividend yield
- None
- 52-week range
- 21.43 – 50.79
- Day range
- 21.73 – 22.15
- Volume / Avg
- 783.47K / 743.01K
- Beta
- —
- Shares outstanding
- 32.56M
- Next earnings
- Nov 5, 2026
52-week range
COLL stock today
Shares of Collegium Pharmaceutical (COLL) finished higher on Oct 7 at $21.93, a gain of 0.23% or $0.05 per share, versus the S&P 500's 0.22% decline. At this level, COLL sits near the bottom of its 52-week range of $21.43 to $50.79: 56.8% below the high, set on Dec 29, 2025 and 2.3% above the low. COLL is down 52.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 34.3%.
Collegium Pharmaceutical trades at 17.3x its trailing twelve-month earnings per share of $1.27. Its forward P/E of 3.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Collegium Pharmaceutical's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Collegium Pharmaceutical
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $1.55
Collegium Pharmaceutical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs COLL |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs COLL |
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs COLL |
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs COLL |
| PHARPharming Group N.V. ADS | 9.65 | -0.31% | $683.01M | vs COLL |
| GYREGyre Therapeutics Inc. | 7.04 | -0.56% | $746.48M | vs COLL |
| VSTMVerastem Inc. | 8.27 | +6.65% | $748.51M | vs COLL |
| APMDApnimed Inc. | 18.04 | -3.27% | $751.02M | vs COLL |
Indexes, lists and sector
Largest Health Care stocks
Collegium Pharmaceutical stock FAQ
What is Collegium Pharmaceutical's stock price today?
COLL last traded at $21.93 as of Oct 7, 4:00 PM EDT, up 0.23% on the day. Prices are delayed at least 15 minutes.
When is Collegium Pharmaceutical's next earnings date?
Collegium Pharmaceutical is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $1.55.
What is COLL's P/E ratio?
COLL trades at a trailing P/E ratio of 17.27 and a forward P/E of 3.30.
What is the COLL 52-week high?
The 52-week high for COLL is $50.79 and the 52-week low is $21.43. The stock is currently 56.8% below its high.